New England Biolabs achieves ISO 14001 recertification

Wednesday, August 22, 2012 01:45 PM

New England Biolabs, a producer and supplier reagents for the life science industry has received ISO 14001 recertification in recognition of the company's dedication to and outstanding record of achievement in its Environmental Management Systems (EMS).

The certification, which was originally awarded to NEB in 2009, is a continuously monitored standard that acknowledges a company's commitment to reducing its impact on the environment.

The recertification process involves extensive site monitoring and auditing of adherence to all established guidelines by National Quality Assurance USA, the independently accredited certification body responsible for assessing ISO 14001 fitness and compliance.

NEB was founded in 1974 on the principle that it was possible to develop world-class molecular biology reagents in an environmentally conscientious way. To minimize the impact that a manufacturing plant can have on its land and natural resources, NEB implemented a SolarAquatics wastewater purification and reclamation system. This system treats the wastewater from the NEB campus and purifies it until it can be used to recharge the delicate Ipswich River Watershed ecosystem. The company also built a 140,000 square-foot LEED-certified research and production facility, and implemented a first-of-its-kind shipping box recycling program, which has been limiting Styrofoam production and encouraging environmentalism amongst NEB's customers for over 30 years.

Another environmental initiative at NEB is its lunchroom composting program, which diverts compostable refuse from local landfills. Each month, NEB diverts 3.5 tons of compostable materials from the landfill and turns it into rich soils to support the company's on-site garden and local farmers.

"At NEB, we strive to create the purest molecular biology products available, and we do so while keeping an eye towards the environment," said Jim Ellard, CEO of New England Biolabs. "Ultimately, this recertification validates our continued vigilance and lets our customers know that we are committed to producing products of the highest quality while preserving the natural splendor of our campus and planet."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs